On Feb. 21, 2018, the Medicines and Healthcare products Regulatory Agency (MHRA), the United Kingdom s regulatory authority, issued a recall of three specific affected lots of respiratory inhalers manufactured by GlaxoSmithKline (GSK).
The recalled lots contained Seretide Accuhaler (50/250Original Article
